Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
In the latest quarter, 6 analysts provided ratings for PACS Group (NYSE:PACS), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 3 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 2 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for PACS Group, presenting an average target of $39.33, a high estimate of $44.00, and a low estimate of $35.00. Witnessing a positive shift, the current average has risen by 15.0% from the previous average price target of $34.20.
The analysis of recent analyst actions sheds light on the perception of PACS Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
David Macdonald | Truist Securities | Raises | Buy | $44.00 | $36.00 |
Scott Fidel | Stephens & Co. | Raises | Overweight | $40.00 | $37.00 |
Jason Cassorla | Citigroup | Raises | Buy | $41.00 | $34.00 |
Michael Wiederhorn | Oppenheimer | Raises | Outperform | $40.00 | $32.00 |
David Macdonald | Truist Securities | Raises | Buy | $36.00 | $32.00 |
Tao Qiu | Macquarie | Announces | Outperform | $35.00 | - |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of PACS Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on PACS Group analyst ratings.
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: PACS Group's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 29.08%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -1.11%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): PACS Group's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -3.12%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): PACS Group's ROA stands out, surpassing industry averages. With an impressive ROA of -0.28%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: PACS Group's debt-to-equity ratio is notably higher than the industry average. With a ratio of 4.67, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PACS